INS and cancer: As PTCL has several subtypes, upregulation of microRNA miR-187 reported across PTCL subtypes is known to decrease glucose-stimulated insulin secretion (GSIS) in metabolic syndromes; however, its role in cancer metabolic reprogramming is unknown (73).